Study #2022-0107
Triage of advanced Cervical cancer through immunotherapy induction (TRACTION)
MD Anderson Study Status
Enrolling
Treatment Agent
Lorigerlimab
Description
To learn if MGD019 can help to control cervical cancer in patients who have yet to receive treatment.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Metastatic Cancer, Cervical Cancer
Study phase:
Phase II
Physician name:
Amir Jazaeri
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.